Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitogen-activated protein kinase 14 (p38α) and mitogen-activated protein kinase 11 (p38β) are members of the p38 MAP kinase subfamily of serine/threonine-specific kinases in humans, encoded by MAPK14 and MAPK11 genes respectively. These kinases serve crucial regulatory roles in signal transduction responding to cellular stress and inflammation, integrating multiple biochemical signals to control diverse cellular processes, including proliferation, differentiation, transcription regulation, programmed cell death, and production of inflammatory cytokines. Both are widely conserved and highly pursued therapeutic targets for a spectrum of diseases marked by aberrant inflammation or stress responses, with numerous drugs developed to inhibit their kinase activity.
Inhibition of kinase activity, preventing phosphorylation of downstream substrates and thus dampening production of inflammatory cytokines and stress-response proteins.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitogen-activated protein kinase 14 and Mitogen-activated protein kinase 11 (p38α and p38β).